Integra LifeSciences Holdings (IART)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	US$ in thousands	246,375	215,157	215,236	591,906	276,402	273,732	309,192	307,367	456,661	511,937	447,152	407,092	513,448	470,231	397,414	408,976	470,166	396,279	360,981	357,712
Short-term investments	US$ in thousands	27,192	62,441	81,691	71,194	32,694	19,938	20,200	15,659	0	13,111	4,369	—	—	—	—	—	—	—	—	—
Total current liabilities	US$ in thousands	922,126	912,563	328,316	302,394	306,980	355,712	377,496	282,293	320,906	304,452	295,596	315,833	340,021	332,858	318,756	412,301	401,013	255,146	212,415	246,485
Cash ratio		0.30	0.30	0.90	2.19	1.01	0.83	0.87	1.14	1.42	1.72	1.53	1.29	1.51	1.41	1.25	0.99	1.17	1.55	1.70	1.45

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($246,375K + $27,192K) ÷ $922,126K
= 0.30

The cash ratio of Integra LifeSciences Holdings has shown fluctuations over the analyzed periods. The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to cover short-term obligations.

From March 31, 2020, to March 31, 2024, the cash ratio varied between 0.83 and 2.19. Notably, the ratio peaked at 2.19 on March 31, 2024, indicating a significant increase in the company's cash reserves relative to short-term liabilities.

Despite some fluctuations, the company generally maintained a healthy cash position over the period, with most values above 1.0, suggesting that it had sufficient cash to cover its short-term obligations. However, a decline in the cash ratio from June 30, 2023, to September 30, 2024, might suggest potential liquidity challenges during that period.

Overall, the company's cash ratio trended positively in the latter part of the analyzed period, indicating an improvement in its ability to cover short-term liabilities with cash and cash equivalents.